February 12, 2020
TB Alliance Names Dr. Daniel Everitt Vice President and Chief Medical Officer
Dr. Everitt to lead development planning of novel drug regimens to treat tuberculosis February 3, 2020
Jane Griffiths Joins TB Alliance Board of Directors
Griffiths has 35 years of experience in the healthcare industry January 30, 2020
TB Research Funding Continues to Fall Short
Statement on 2019 G-FINDER Report January 29, 2020
TB Alliance Partners with ERA4TB, an International Consortium to Accelerate the Development of Comprehensive Treatments against Tuberculosis
More than 30 partners from 13 countries participate in the ERA4TB project January 27, 2020
New Research Assesses Efficacy of Different Doses of Linezolid, Key Medicine Used in Regimens that Treat Drug-Resistant Tuberculosis
January 16, 2020
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China
Non-profit drug developer partners with leading manufacturer of tuberculosis medicine in China November 13, 2019